Onkologie. 2010:4(2):75-78

Brachytherapy for prostate cancer

Renata Soumarová
Komplexní onkologické centrum Nový Jičín

The optimal treatment for localized prostate cancer has not been clearly defined. It is possible to use radical prostatectomy, external

radiotherapy, brachytherapy or, in some cases, the strategy of active surveillance. In recent years, interstitial brachytherapy has been

advancing rapidly due to the development of ultrasound-guided techniques, new radioisotopes and more advanced planning systems.

It is an excellent method for high-dose delivery within the prostate with a very low rate of serious complications. Brachytherapy can be

performed by permanent implantation of radioisotopes into the prostate or by using high-dose rate temporary brachytherapy. Both

methods can and, in some cases, should be combined with external radiotherapy. However, the best technique for brachytherapy has

not been determined and the selection largely depends on the expertise of the staff. In addition to treatment outcomes, it is of major

importance to be aware of the possible adverse effects of treatment with respect to the quality of life of patients.

Keywords: prostate cancer, brachytherapy, interstitial brachytherapy, permanent implantation

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Soumarová R. Brachytherapy for prostate cancer. Onkologie. 2010;4(2):75-78.
Download citation

References

  1. Bujdák P, Cuninková M. Karcinóm prostaty - trendy výskytu a rizikové faktory. Urologie pro praxi 2004; 5(4): 169-171.
  2. Kupelian PA. Comparison of the efficacy of local therapies for localized prostate cancer in the PSA era: a large single-institution experience with radical prostatectomy and externalbeam radiotherapy. J Clin Oncol 2002; 20(16): 3376-3385. Go to original source... Go to PubMed...
  3. Kupelian PA, Potters L, Khuntia D, et al. Radical prostatectomy, external beam radiotherapy < 72 Gy, external beam radiotherapy >= 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58(1): 25-32. Go to original source... Go to PubMed...
  4. Norderhaug I, Dahl O, H?isaeter PA, et al. Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness. Eur Urol 2003; 44(1): 40-46. Review. Go to original source... Go to PubMed...
  5. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M.D.Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53(5): 1097-1105. Go to original source... Go to PubMed...
  6. Kupelian PA, Mohan DS, Lyons J, et al. Higher than standard radiation dose (72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 2000; 46(3): 567-574. Go to original source... Go to PubMed...
  7. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41(3): 491-500. Go to original source... Go to PubMed...
  8. Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 1988; 15(6): 1299-1305. Go to original source... Go to PubMed...
  9. Valicenti R, Lu J, Pilepich M, et al. Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials. J Clin Oncol 2000; 18(14): 2740-2746. Go to original source... Go to PubMed...
  10. Kupelian P, Kuban D, Thames H, et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys 2005; 61(2): 415-419. Go to original source... Go to PubMed...
  11. Russell KJ, Caplan RJ, Laramore GE, et al. Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial. Int J Radiat Oncol Biol Phys 1994; 28(1): 47-54. Go to original source... Go to PubMed...
  12. Batterman J. Seed techniques. ESTRO-EAU Teaching course on Brachytherapy for Prostate Cancer. Leeds, 2004: 128.
  13. Buron C, Le Vu B, Cosset JM, et al. Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economy study. Int J Radiat Oncol Biol Phys 2007; 67(3): 812-822. Go to original source... Go to PubMed...
  14. Fischer GS, DiMaio SP, Iordachita II, Fichtinger G. Robotic assistant for transperineal prostate interventions in 3T closed MRI. Med Image Comput Comput Assist Interv 2007; 10(Pt 1): 425-433. Go to original source... Go to PubMed...
  15. Vicini FA, Kini VR, Edmundson G, et al. A comprehensive review of prostate cancer brachytherapy: defining an optimal technique. Int J Radiat Biol Phys 1999; 44(3): 483-491. Go to original source... Go to PubMed...
  16. Ash D, Flynn A, Battermann J, et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000; 57: 315-321. Go to original source... Go to PubMed...
  17. Nag S, Beyer D, Friedland J, et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999; 44(4): 789-799. Go to original source... Go to PubMed...
  18. Sylvester JE, Blasko JC, Grimm R, et al. Fifteen year followup of the first cohort of localized prostate cancer patients treated with brachytherapy. J Clin Oncol 2004; 22: 4567. Go to original source... Go to PubMed...
  19. Zelefsky MJ, Kuban DA, Levy LB, et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007; 67(2): 327-333. Go to original source... Go to PubMed...
  20. Kovacs G, Pötter R, Tillmann L, et al. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol 2005; 74: 137-148. Go to original source... Go to PubMed...
  21. Pietersa BR, van de Kamera JB, van Hertena YRJ. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy. Radiother Oncol 2008; 88: 46-52. Go to original source... Go to PubMed...
  22. Viani GA, Stefano EJ, Afonso SL. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 2009; 74(5): 1405-1418. Review. Go to original source... Go to PubMed...
  23. Soumarová R, Homola L, Štursa M, Perková H. Acute Toxicity of Conformal High Dose Interstitial Brachytherapy Boost in Prostate Cancer. Neoplasma 2006; 53(5): 410-417.
  24. Ferrer M, Suárez JF, Guedea F, et al. Health-Related Quality of Life 2 Years After Treatment With Radical Prostatectomy, Prostate Brachytherapy, or External Beam Radiotherapy in Patients With Clinically Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2008; 72(2): 421-432. Go to original source... Go to PubMed...
  25. Frank SJ, Pisters LL, Davis J, et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 2007; 177(6): 2151-2156. Go to original source... Go to PubMed...
  26. Robinson JW, Moritz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002; 54(4): 1063-1068. Go to original source... Go to PubMed...
  27. Burnett AL, Aus G, Canby-Hagino ED, et al. American Urological Association Prostate Cancer Guideline Update Panel. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol 2007; 178(2): 597-601. Go to original source... Go to PubMed...
  28. Henderson A, Laing RW, Langley SE. Quality of life following treatment for early prostate cancer: does low dose rate (LDR) brachytherapy offer a better outcome? A review. Eur Urol 2004; 45(2): 134-141. Review. Go to original source... Go to PubMed...
  29. Stock RG, Stone NN, Cesaretti JA. Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications. Int J Radiat Oncol Biol Phys 2003; 56(2): 448-453. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.